Does the IRF5 rs2004640 T allele drive innate inflammatory and type I interferon responses without raising CRP?

The association between the IRF5 rs2004640 variant and a distinct inflammatory profile is well-supported by genetic and mechanistic research. This polymorphism, particularly the T allele, serves as a functional driver of innate immune activation through both increased expression and enhanced molecular signaling.

Genetic and Molecular Evidence

Studies across diverse populations, including European and East Asian cohorts, consistently link the rs2004640 T allele to higher levels of IRF5 mRNA. In patients with systemic autoimmune conditions, this variant demonstrates a dose-dependent effect on expression. Beyond transcription, the variant is associated with basal hyper-activation of the IRF5 protein within the myeloid compartment. This leads to an "at-ready" inflammatory state where monocytes are more likely to polarize toward a pathogenic M1-type macrophage phenotype (CD11c+) rather than an anti-inflammatory state.

Mechanistic Signaling Pathways

• Type I Interferon Induction: IRF5 is a primary transcription factor for the induction of Type I interferons (IFN-α and IFN-β). Upon activation via Toll-like receptors (TLR7/8/9), IRF5 homodimers bind directly to interferon gene promoters.
• Pro-inflammatory Biasing: Higher IRF5 activity shifts monocyte differentiation and metabolic pathways—specifically increasing glycolysis and Akt2 activation—to favor the production of pro-inflammatory mediators such as TNF-α and IL-12.
• CRP Discordance: A hallmark of IRF5-mediated inflammation is the "CRP discordance" phenomenon. While traditional inflammation (driven by IL-6) triggers hepatic C-reactive protein production, the Type I IFN signature driven by IRF5 is mechanistically independent of the IL-6/CRP axis. Consequently, individuals may exhibit significant monocyte-driven tissue inflammation and high interferon-stimulated gene (ISG) expression while maintaining normal or only mildly elevated CRP levels.

Bottom line

The IRF5 rs2004640 T allele drives a specific "high-IFN" inflammatory phenotype by increasing IRF5 expression and biasing monocyte differentiation. This pathway is clinically significant because it can sustain chronic innate immune activation and type I interferon signaling without triggering a corresponding rise in systemic CRP, potentially masking underlying inflammation in standard clinical screenings.